Diaceutics (DXRX) News Today GBX 147.90 +2.90 (+2.00%) As of 01/17/2025 11:52 AM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Diaceutics (LON:DXRX) Hits New 1-Year High - Here's What HappenedDiaceutics (LON:DXRX) Sets New 1-Year High - Should You Buy?January 8, 2025 | marketbeat.comDiaceutics PLC Enhances Employee Engagement Through Share Incentive PlanJanuary 3, 2025 | tipranks.comDiaceutics (LON:DXRX) Sets New 52-Week High - What's Next?Diaceutics (LON:DXRX) Hits New 52-Week High - Time to Buy?January 2, 2025 | marketbeat.comDiaceutics PLC Announces Major Shareholding ChangeDecember 19, 2024 | tipranks.comCanaccord Genuity Group Reaffirms Buy Rating for Diaceutics (LON:DXRX)Canaccord Genuity Group reaffirmed a "buy" rating and issued a GBX 160 ($2.03) price target on shares of Diaceutics in a research note on Tuesday.December 18, 2024 | marketbeat.comDiaceutics' (DXRX) "Buy" Rating Reiterated at Canaccord Genuity GroupCanaccord Genuity Group reissued a "buy" rating and issued a GBX 160 ($2.03) target price on shares of Diaceutics in a research note on Tuesday.December 17, 2024 | marketbeat.comDiaceutics Expands US Market with New PartnershipsNovember 28, 2024 | tipranks.comDiaceutics (LON:DXRX) Stock Price Down 1.6% - What's Next?Diaceutics (LON:DXRX) Stock Price Down 1.6% - Here's WhyOctober 24, 2024 | marketbeat.comDiaceutics PLC (LON:DXRX) Insider Acquires £150.08 in StockOctober 3, 2024 | insidertrades.comDiaceutics PLC (LON:DXRX) Insider Purchases £150.08 in StockDiaceutics PLC (LON:DXRX - Get Free Report) insider Nick Roberts purchased 112 shares of the firm's stock in a transaction on Monday, September 30th. The stock was bought at an average price of GBX 134 ($1.79) per share, with a total value of £150.08 ($200.75).October 2, 2024 | marketbeat.comDiaceutics (LON:DXRX) Given "Buy" Rating at Canaccord Genuity GroupCanaccord Genuity Group reissued a "buy" rating and issued a GBX 160 ($2.11) price target on shares of Diaceutics in a research note on Tuesday.September 17, 2024 | marketbeat.comInsider Buying: Diaceutics PLC (LON:DXRX) Insider Buys 113 Shares of StockAugust 31, 2024 | insidertrades.comInsider Buying: Diaceutics PLC (LON:DXRX) Insider Acquires 113 Shares of StockDiaceutics PLC (LON:DXRX - Get Free Report) insider Nick Roberts acquired 113 shares of the firm's stock in a transaction on Wednesday, August 28th. The shares were bought at an average price of GBX 134 ($1.77) per share, for a total transaction of £151.42 ($199.68).August 30, 2024 | marketbeat.comCanaccord Genuity Group Reiterates "Buy" Rating for Diaceutics (LON:DXRX)Canaccord Genuity Group reiterated a "buy" rating and set a GBX 160 ($2.08) price target on shares of Diaceutics in a research note on Tuesday.August 20, 2024 | marketbeat.comDiaceutics (LON:DXRX) Reaches New 12-Month High at $135.00Diaceutics (LON:DXRX) Sets New 1-Year High at $135.00July 19, 2024 | marketbeat.comDiaceutics (LON:DXRX) Trading 0.4% Higher Diaceutics (LON:DXRX) Trading 0.4% HigherJune 28, 2024 | marketbeat.comDiaceutics (LON:DXRX) Sets New 52-Week High at $135.00Diaceutics (LON:DXRX) Sets New 52-Week High at $135.00June 4, 2024 | marketbeat.comDiaceutics (LON:DXRX) Hits New 1-Year High at $130.00Diaceutics (LON:DXRX) Reaches New 52-Week High at $130.00May 28, 2024 | marketbeat.comDiaceutics PLC (LON:DXRX) Insider Purchases £51,514.86 in StockMay 24, 2024 | insidertrades.comDiaceutics (LON:DXRX) Hits New 1-Year High at $129.00Diaceutics (LON:DXRX) Sets New 52-Week High at $129.00May 22, 2024 | marketbeat.comDiaceutics (LON:DXRX) Reaches New 1-Year High at $110.25Diaceutics (LON:DXRX) Reaches New 52-Week High at $110.25May 16, 2024 | marketbeat.comDiaceutics (LON:DXRX) Trading Up 1.5%Diaceutics (LON:DXRX) Stock Price Up 1.5%May 16, 2024 | marketbeat.comPeter Keeling Sells 750,000 Shares of Diaceutics PLC (LON:DXRX) StockApril 3, 2024 | insidertrades.comInsider Selling: Diaceutics PLC (LON:DXRX) Insider Sells 750,000 Shares of StockDiaceutics PLC (LON:DXRX - Get Free Report) insider Peter Keeling sold 750,000 shares of Diaceutics stock in a transaction dated Thursday, March 28th. The stock was sold at an average price of GBX 102 ($1.28), for a total transaction of £765,000 ($960,331.41).April 2, 2024 | marketbeat.comCanaccord Genuity Group Reiterates Buy Rating for Diaceutics (LON:DXRX)Canaccord Genuity Group reiterated a "buy" rating and set a GBX 150 ($1.91) price target on shares of Diaceutics in a research report on Thursday.March 21, 2024 | marketbeat.comDiaceutics PLC (LON:DXRX) Insider Acquires £33,228.36 in StockMarch 17, 2024 | insidertrades.comDiaceutics (LON:DXRX) shareholders have endured a 41% loss from investing in the stock three years agoOctober 26, 2023 | finance.yahoo.comCalculating The Intrinsic Value Of Diaceutics PLC (LON:DXRX)October 26, 2023 | finance.yahoo.comDiaceutics First Half 2023 Earnings: EPS Beats ExpectationsOctober 26, 2023 | finance.yahoo.comDiaceutics PLC (LON:DXRX) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies AheadApril 20, 2023 | finance.yahoo.comDiaceutics PLC (LON:DXRX) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?April 20, 2023 | finance.yahoo.comDiaceutics 2022 Pretax Profit Rose on Growing DemandApril 17, 2023 | marketwatch.comDiaceutics Suspends Share Trading as SVB Closure Restricts Access to Its FundsMarch 13, 2023 | marketwatch.comThose who invested in Diaceutics (LON:DXRX) a year ago are up 13%March 10, 2023 | finance.yahoo.comBroker Revenue Forecasts For Diaceutics PLC (LON:DXRX) Are Surging HigherJanuary 28, 2023 | finance.yahoo.comTRADING UPDATES: Diaceutics wins two deals; Faron proposes placingJanuary 27, 2023 | lse.co.ukAn Intrinsic Calculation For Diaceutics PLC (LON:DXRX) Suggests It's 40% UndervaluedDecember 9, 2022 | finance.yahoo.comDanske Bank supported the purchase of the new building at Kings Hall Life Sciences ParkNovember 28, 2022 | msn.comEdited Transcript of DXRX.L earnings conference call or presentation 28-Sep-22 12:00pm GMTSeptember 29, 2022 | finance.yahoo.comDEWA and WGEO Complete Preparations for 8th Edition of the World Green Economy SummitSeptember 16, 2022 | nz.finance.yahoo.comBake Off star Laura Adlington reveals she was left suicidal after trolls fat-shamed her on social mediaSeptember 16, 2022 | yahoo.comDiaceutics PLC (DXRX.L)August 14, 2022 | uk.finance.yahoo.comIs Diaceutics PLC (LON:DXRX) Trading At A 32% Discount?July 2, 2022 | finance.yahoo.comDiaceutics wins USD2 million contract with "top five global" drug firmJune 13, 2022 | lse.co.ukDiaceutics PLC (LON:DXRX) Has Varied Financials: Could That Be Why Its Recent Performance Has Been Uneventful?May 23, 2022 | finance.yahoo.comDiaceutics inks five-year deal with existing pharma partnerMay 5, 2022 | lse.co.ukThe past year for Diaceutics (LON:DXRX) investors has not been profitableApril 7, 2022 | finance.yahoo.comDiaceutics returns to pretax profit in 2021 and ups revenueMarch 22, 2022 | lse.co.ukDiaceutics Approved by US Agency to Receive Enhanced DataMarch 16, 2022 | marketwatch.comDiaceutics Gets Three-Year Contract Worth More Than $2.5 MlnFebruary 14, 2022 | marketwatch.com Get Diaceutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DXRX and its competitors with MarketBeat's FREE daily newsletter. Email Address DXRX Media Mentions By Week DXRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DXRX News Sentiment▼0.000.53▲Average Medical News Sentiment DXRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DXRX Articles This Week▼00▲DXRX Articles Average Week Get Diaceutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DXRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ANGLE News Today Abingdon Health News Today Proteome Sciences News Today genedrive News Today Uniphar News Today Oxford Biomedica News Today Advanced Medical Solutions Group News Today MaxCyte News Today Allergy Therapeutics News Today PureTech Health News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:DXRX) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Diaceutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Diaceutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DXRX Stock Alerts